New Delhi: Bharat Biotech has released the third phase data. The company has claimed 81% Efficiency (Effectiveness). According to the company, 25800 participants were included in the third phase. On the interim data of 43 cases, it was observed that in 36 cases covaccine was found to have placebo in 7 cases. India Biotech claims that covaxine is up to 81% effective against the UK corona virus strain.
Significantly, the development of covaccin has been done entirely in India. Hyderabad-based renowned vaccine manufacturer Bharat Biotech has said that Prime Minister Narendra Modi has set an example by taking the first dose of Corona virus vaccine and his move will give a boost to the ongoing vaccination campaign against the epidemic.
It is known that the second phase of anti-Corona virus infection vaccination started on Monday from March 1 across the country, during this period, the vaccine dose for people 60 years or older and 45-59 years old people suffering from any chronic disease. will be given. On the first day of the second phase, the Prime Minister reached the All India Institute of Medical Sciences (AIIMS) in the national capital and took the first dose of covicin, developed by Bharat Biotech.
